Emerging research suggests time-restricted feeding may improve symptoms and slow neurodegeneration in Huntington’s disease through circadian rhythm synchronization and enhanced autophagy. New cl...
Recent studies highlight the efficacy of Mediterranean and plant-based diets, omega-3s, and vitamin D in mitigating side effects of aromatase inhibitors in breast cancer patients. Emerging research re...
Exploring how konjac glucomannan and other prebiotics influence weight through gut-brain communication, with insights from recent studies and practical dietary strategies. Recent research reveals how ...
Innovative cubosome delivery systems are transforming arthritis treatment by significantly improving the bioavailability and efficacy of herbal compounds like turmeric and boswellia. Breakthrough cubo...
Recent research reveals how intermittent fasting protocols interact with circadian rhythms to improve insulin sensitivity, gut microbiome diversity, and metabolic markers beyond weight loss. Emerging ...
New research reveals curcumin’s significant effects on blood sugar control and blood pressure reduction, offering a natural adjunct to conventional diabetes and hypertension treatments. Recent c...
A 12-week clinical trial explores time-restricted eating’s potential to enhance mitochondrial function and reduce oxidative stress in early-stage Huntington’s disease. A new clinical trial inv...
Prenatal PFAS exposure linked to lifelong maternal diabetes risk and epigenetic changes in offspring
New research reveals prenatal PFAS exposure significantly increases maternal diabetes risk and may cause epigenetic changes affecting offspring metabolic health. Groundbreaking studies show PFAS chemi...
A pilot study confirms the safety of intravenous BPC-157 in humans, with potential applications in sports medicine and rehabilitation. New human data suggests intravenous BPC-157 may be safe, opening ...
New research highlights how targeted dietary interventions can alleviate side effects of endocrine therapy, with omega-3s and vitamin D showing particular promise for symptom management. Cutting-edge ...
